State Of New Jersey Common Pension Fund D Mirati Therapeutics, Inc. Transaction History

State Of New Jersey Common Pension Fund D

$23.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$41.99 - $62.38 $981,264 - $1.46 Million	-23,369 Reduced 34.67%	44,027 $2.59 Million
Q3 2023 Nov 08, 2023	BUY	$27.8 - $45.35 $1.87 Million - $3.06 Million	67,396 New	67,396 $2.94 Million
Q1 2023 Apr 26, 2023	BUY	$36.54 - $54.26 $856,716 - $1.27 Million	23,446 Added 86.88%	50,434 $1.88 Million
Q4 2022 Feb 01, 2023	SELL	$41.27 - $98.62 $175,603 - $419,628	-4,255 Reduced 13.62%	26,988 $1.22 Million
Q3 2022 Oct 28, 2022	SELL	$59.5 - $86.7 $274,711 - $400,293	-4,617 Reduced 12.88%	31,243 $2.18 Million
Q2 2022 Aug 04, 2022	BUY	$39.16 - $88.71 $304,234 - $689,187	7,769 Added 27.66%	35,860 $2.41 Million
Q1 2022 May 03, 2022	BUY	$75.82 - $150.97 $282,429 - $562,363	3,725 Added 15.29%	28,091 $2.31 Million
Q4 2021 Jan 31, 2022	SELL	$132.01 - $190.29 $70,757 - $101,995	-536 Reduced 2.15%	24,366 $3.57 Million
Q3 2021 Oct 27, 2021	BUY	$132.13 - $177.45 $289,628 - $388,970	2,192 Added 9.65%	24,902 $4.41 Million
Q2 2021 Jul 23, 2021	BUY	$144.0 - $179.73 $62,352 - $77,823	433 Added 1.94%	22,710 $3.67 Million
Q1 2021 Apr 27, 2021	BUY	$158.92 - $221.61 $532,223 - $742,171	3,349 Added 17.69%	22,277 $3.82 Million
Q4 2020 Feb 03, 2021	SELL	$162.05 - $240.27 $213,906 - $317,156	-1,320 Reduced 6.52%	18,928 $4.16 Million
Q3 2020 Oct 27, 2020	SELL	$113.26 - $167.27 $57,875 - $85,474	-511 Reduced 2.46%	20,248 $3.36 Million
Q2 2020 Aug 04, 2020	SELL	$72.01 - $120.39 $138,403 - $231,389	-1,922 Reduced 8.47%	20,759 $2.37 Million
Q4 2019 Jan 31, 2020	BUY	$70.76 - $128.86 $69,415 - $126,411	981 Added 4.52%	22,681 $2.92 Million
Q3 2019 Oct 23, 2019	BUY	$77.91 - $109.6 $1.69 Million - $2.38 Million	21,700 New	21,700 $1.69 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.

Account